CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on October 17, 2007
Clinical Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.2215/CJN.01520407
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.01520407v1
2/6/1283    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felsenfeld, A. J.
Right arrow Articles by Aguilera-Tejero, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felsenfeld, A. J.
Right arrow Articles by Aguilera-Tejero, E.


IN-DEPTH REVIEWS

Dynamics of Parathyroid Hormone Secretion in Health and Secondary Hyperparathyroidism

Arnold J. Felsenfeld *1, Mariano Rodríguez {dagger}, and Escolástico Aguilera-Tejero {ddagger}

*Department of Medicine, VA Greater Los Angeles Healthcare System and University of California Los Angeles, Los Angeles, California; and {dagger}Department Nefrología y Unidad de Investigación, Hospital Universitario Reina Sofia, and {ddagger}Department Medicina y Cirugía Animal, Universidad de Córdoba, Córdoba, Spain


1 To whom correspondence should be addressed. E-mail: Arnold.Felsenfeld{at}med.va.gov.


   Abstract

This review examines the dynamics of parathyroid hormone secretion in health and in various causes of secondary hyperparathyroidism. Although most studies of parathyroid hormone and calcium have focused on the modification of parathyroid hormone secretion by serum calcium, the relationship between parathyroid hormone and serum calcium is bifunctional because parathyroid hormone also modifies serum calcium. In normal animals and humans, factors such as phosphorus and vitamin D modify the basal parathyroid hormone level and the maximal parathyroid hormone response to hypocalcemia. Certain medications, such as lithium and estrogen, in normal individuals and sustained changes in the serum calcium concentration in hemodialysis patients change the set point of calcium, which reflects the serum calcium concentration at which parathyroid hormone secretion responds. Hypocalcemia increases the basal/maximal parathyroid hormone ratio, a measure of the relative degree of parathyroid hormone stimulation. The phenomenon of hysteresis, defined as a different parathyroid hormone value for the same serum calcium concentration during the induction of and recovery from hypo- and hypercalcemia, is discussed because it provides important insights into factors that affect parathyroid hormone secretion. In three causes of secondary hyperparathyroidism—chronic kidney disease, vitamin D deficiency, and aging—factors that affect the dynamics of parathyroid hormone secretion are evaluated in detail. During recovery from vitamin D deficiency, the maximal parathyroid hormone remains elevated while the basal parathyroid hormone value rapidly becomes normal because of a shift in the set point of calcium. Much remains to be learned about the dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society of Nephrology.